Sales revenue ToolGen 2015-2024
In 2024, the revenue of ToolGen amounted to nearly 891 million South Korean won. This represents a decrease compared to the previous year's amount. ToolGen is a South Korean biotech company specialized in CRISPR genome editing technology.